TET2 ADDITIONAL MUTATIONS AT DIAGNOSIS IMPACT THE RESPONSE OF FIRST-LINE TREATMENT WITH HYDROXYUREA OR INTERFERON-Α IN ESSENTIAL THROMBOCYTHEMIA

EHA Library, Carole Mosnier, 419096

FRONTLINE BRENTUXIMAB VEDOTIN AND CHP (A+CHP) IN PATIENTS (PTS) WITH PERIPHERAL T-CELL LYMPHOMA WITH LESS THAN 10% CD30 EXPRESSION: RESULTS FROM THE PHASE 2 SGN35-032 STUDY

EHA Library, Swaminathan Iyer, 419244

BRIGATINIB MONOTHERAPY IN CHILDREN WITH R/R ALK+ ALCL: PRELIMINARY RESULTS FROM THE BRIGAPED (ITCC-098) PHASE 1 DOSE-ESCALATION STUDY

EHA Library, Charlotte Rigaud, 419245

ZUMA-24 PRELIMINARY ANALYSIS: A PHASE 2 STUDY OF AXICABTAGENE CILOLEUCEL IN THE OUTPATIENT SETTING WITH PROPHYLACTIC CORTICOSTEROIDS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Lori Leslie, 419246

A CRISPR-EDITED ALLOGENEIC ANTI-CD19 CAR-T CELL THERAPY WITH A PD-1 KNOCKOUT (CB-010) FOR RELAPSED/REFRACTORY B CELL NON-HODGKIN LYMPHOMA (R/R B-NHL): UPDATED PHASE 1 RESULTS FROM THE ANTLER TRIAL

EHA Library, Boyu Hu, 419247

EPCORITAMAB + R-DHAX/C ELICITS DEEP, DURABLE RESPONSES IN TRANSPLANT-ELIGIBLE PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING HIGH-RISK DISEASE

EHA Library, Pau Abrisqueta, 419248

ODRONEXTAMAB DEMONSTRATES DURABLE COMPLETE RESPONSES IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PROGRESSING AFTER CAR-T THERAPY: OUTCOMES FROM THE ELM-1 STUDY

EHA Library, Jean-Marie Michot, 419249

PLASMA CELL-FREE DNA AS AN ALTERNATIVE TO TISSUE DNA FOR DETECTING GENETIC ALTERATIONS OF IVLBCL

EHA Library, Chao Chen, 419250

SUPERIOR EFFECTS OF CD19/20 DUAL-TARGETING CAR-T IN PATIENTS WITH RELAPSED/REFRACTIVE B-CELL LYMPHOMA: A MULTICENTER PRELIMINARY INTERIM REPORT

EHA Library, Jiaqi Guo, 419251

ANBALCABTAGENE AUTOLEUCEL (PD-1 AND TIGIT KNOCK-DOWNED CD19 CAR-T) FOR RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA PATIENTS: RESULT OF A PIVOTAL PHASE 2 STUDY.

EHA Library, Won-Seog Kim, 419252

REAL-WORLD ANALYSIS OF GLOFITAMAB FOR RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA IN GERMANY, AUSTRIA AND SWITZERLAND

EHA Library, Rebecca Wurm-Kuczera, 419253

ORIENT STUDY: ORELABRUTINIB ADDITION TO R-CHOP-LIKE REGIMEN ADAPTED TO RESPONSE IN TREATMENT-NAÏVE NON-GCB DLBCL

EHA Library, Chang-Ju Qu, 419254

PHASE I-II STUDY COMBINING BRENTUXIMAB VEDOTIN WITH R-DHAP AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN CD30 POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: RESULTS OF THE HOVON 136 STUDY

EHA Library, Pieternella (Elly) Lugtenburg, 419255

GENOMIC PROFILING IN A SUBGROUP ANALYSIS OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AND EXTRANODAL (EN) SITES OF INVOLVEMENT IN THE PHASE III POLA-R-CHP VERSUS R-CHOP (POLARIX) STUDY

EHA Library, Gilles Salles, 419256

PHASE 2 STUDY OF ANTI-PD-L1 ANTIBODY ATEZOLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA: NCCH1903/ATTACK STUDY

EHA Library, Shinichi Makita, 419257

COMPARISON OF ZUBERITAMAB PLUS CHOP WITH RITUXIMAB PLUS CHOP FOR THE TREATMENT OF DRUG-NAÏVE PATIENTS DIAGNOSED WITH CD20-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA: A PHASE 3 TRIAL

EHA Library, Zhi-Ming Li, 419258

VALEMETOSTAT MONOTHERAPY IN RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMAS: A FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL

EHA Library, Dai Maruyama, 419259

FEASABILITY AND SAFETY DATA OF THE CHEMOTHERAPY-LIGHT COMBINATION OF RITUXIMAB, POLATUZUMAB VEDOTIN AND GLOFITAMAB IN AGGRESSIVE B-CELL LYMPHOMA PATIENTS INELIGIBLE FOR FULLY DOSED R-CHOP

EHA Library, Rebecca Wurm-Kuczera, 419260

ANALYSIS OF CCND3 MUTATIONS IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Jin-Hua Liang, 419261

ZANUBRUTINIB AND RITUXIMAB REGIMEN COMBINED WITH INTRAVITREAL METHOTREXATE FOLLOWED BY ZANUBRUTINIB MAINTENANCE FOR PRIMARY VITREORETINAL LYMPHOMA: A PROSPECTIVE PROOF-OF-CONCEPT PHASE II STUDY

EHA Library, Yan Zhang, 419262

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD) - FINNISH REAL-LIFE DATA WITH LONG-TERM FOLLOW-UP ON 215 SOLID ORGAN RECIPIENTS

EHA Library, Terhi Friman, 419263

THE PROGNOSTIC SIGNIFICANCE OF MYC/BCL2 DOUBLE EXPRESSION IN DIFFUSE LARGE B CELL LYMPHOMA IN THE GENETIC CLASSIFICATION ERA

EHA Library, Jin-Hua Liang, 419264

BRENTUXIMAB VEDOTIN IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS– UPDATED ANALYSIS OF REAL-WORLD DATA

EHA Library, Magdalena Klanova, 419265

FRONTLINE TREATMENT CHOICES AND GENETIC CHARACTERISTICS OF PATIENTS WITH UNTREATED AGGRESSIVE B-CELL LYMPHOMA WITH SYNCHRONOUS CNS AND SYSTEMIC INVOLVEMENT.

EHA Library, Jacopo Calabrese De Feo, 419267

CD19/BCMA DUAL-TARGETING FASTCAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA: AN UPDATE

EHA Library, Xinfeng Chen, 419268

REAL-WORLD EXPERIENCE OF POLATUZUMAB VEDOTIN COMBINED WITH RITUXIMAB AND BENDAMUSTINE IN RELAPSED AND REFRACTORY LARGE B-CELL LYMPHOMAS.

EHA Library, Michał Danecki, 419269

PREDICTING THE TRULY LOW-RISK PATIENTS WITH TNFRSF14 MUTATION USING MACHINE LEARNING ALGORITHMS IN DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Jin-Hua Liang, 419270

A VISUAL NOMOGRAM SURVIVAL PREDICTION MODEL IN ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)-RELATED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, chongling Hu, 419271

ZANUBRUTINIB, LENALIDOMIDE, RITUXIMAB, TEMOZOLOMIDE AND METHOTREXATE (RLZT±MTX) AS FIRST-LINE TREATMENT FOR NEWLY DIAGNOSED PCNSL: A PROSPECTIVE, OPEN-LABEL, MULTICENTER CLINICAL TRIAL

EHA Library, Jia Song, 419272

SIGNIFICANT OUTCOME IMPROVEMENT OF THE ENTIRE R/R DLBCL POPULATION RECEIVING THIRD LINE THERAPY IN THE CAR T-CELL ERA

EHA Library, Marek Trneny, 419273

EXPLORATION OF THE OPTIMAL TREATMENT MODALITY FOR VITREORETINAL LYMPHOMA: A PRISMA COMPLIANT META-ANALYSIS AND SYSTEMATIC REVIEW

EHA Library, Liang Wang, 419274

BASELINE PET TOTAL METABOLIC TUMOR VOLUME HAS A PROGNOSTIC ROLE IN PTCLS – DATA FROM INTERNATIONAL PROSPECTIVE T-CELL PROJECT 2.0

EHA Library, Tetiana Skrypets, 419275

CD22-TARGETED CAR T CELL SINGLE CELL MULTIOMIC FEATURES LINKED TO PATIENT OUTCOMES IN CD19-CAR RESISTANT LARGE B CELL LYMPHOMA

EHA Library, Anne Marijn Kramer, 419276

TUMOR MUTATIONS AND IMMUNOHISTOCHEMICAL TUMOR EXPRESSION IMPACTS SURVIVAL IN PATIENTS WITH B CELL LYMPHOMA TREATED WITH BISPECIFIC CD20XCD3 ANTIBODIES

EHA Library, Emil Kyvsgaard, 419277

UPDATED TRENDS IN REAL-WORLD OUTPATIENT (OP) ADMINISTRATION OF AXICABTAGENE CILOLEUCEL (AXI-CEL) AND BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) IN RELAPSED/REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL)

EHA Library, Radhika Bansal, 419278

CAR-T CELL THERAPY SHOWS SIMILAR EFFICACY AND TOXICITY IN PATIENTS WITH DLBCL AGED 70 AND OLDER COMPARED TO YOUNGER PATIENTS: A MULTICENTER COHORT STUDY

EHA Library, Philipp Berning, 419279

THE PRIMARY RESULTS OF R-MTO REGIMEN (RITUXIMAB, METHOTREXATE, THIOTEPA, AND ORELABRUTINIB) AS THE FIRST-LINE INDUCTION THERAPY IN NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Zengjun Li, 419280

ORELABRUTINIB IN COMBINATION WITH PD-1 INHIBITOR IN REFRACTORY OR RELAPSED PRIMARY CNS LYMPHOMA

EHA Library, Yan Zhang, 419281

PHASE IB/II STUDY OF RITUXIMAB, LENALIDOMIDE, AND METHOTREXATE FOLLOWED BY LENALIDOMIDE MAINTENANCE IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: THE REMLA TRIAL

EHA Library, Yan Zhang, 419282

IMPACT OF CD19 EXPRESSION BY IMMUNOHISTOCHEMISTRY IN LYMPHOMA PATIENTS TREATED WITH AXICABTAGENE CILOLEUCEL

EHA Library, Marcos Rivada, 419283

DECREASES IN LEFT VENTRICULAR FUNCTION IN ELDERLY PATIENTS WITH LARGE B-CELL LYMPHOMA RECEIVING CHOP REGIMENS IN THE RICOVER-60 TRIAL: RISK FACTORS AND OUTCOMES

EHA Library, Igor Age Kos, 419284

NIVOLUMAB CONSOLIDATION AFTER DA-EPOCH-R INDUCTION INDUCES HIGH RATES OF DISEASE-FREE AND OVERALL SURVIVAL IN PATIENTS WITH DOUBLE AND TRIPLE HIT HIGH-GRADE B-CELL LYMPHOMA

EHA Library, Martine Chamuleau, 419285

REAL-WORLD OUTCOMES OF AXICABTAGENE CILOLEUCEL FOR TREATMENT OF RELAPSED OR REFRACTORY LARGE B CELL LYMPHOMA IN CANADA

EHA Library, Christopher Lemieux, 419286

ANATOMICAL PATTERN OF CNS RELAPSE IN AGGRESSIVE B-CELL LYMPHOMAS

EHA Library, Izel Okcu, 419287

CLINICAL CHARACTERISTICS, TREATMENTS, AND OUTCOMES OF LARGE B-CELL LYMPHOMA PATIENTS IN THIRD-LINE THERAPY INCLUDED BETWEEN 2018 AND 2023 IN THE FRENCH PROSPECTIVE MULTICENTRIC REALYSA COHORT

EHA Library, Caterina Cristinelli, 419288

EARLY PET EVALUATION AT DAY 14 POST AXICABTAGENE CILOLEUCEL INFUSION PREDICTS OUTCOME IN LARGE B-CELL LYMPHOMA: RESULTS FROM THE ALYCANTE PHASE II STUDY

EHA Library, Yassine Al Tabaa, 419289

TAFASITAMAB PLUS LENALIDOMIDE AS SALVAGE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: THE SPANISH GROUP OF LYMPHOMA (GELTAMO) REAL-WORLD EXPERIENCE.

EHA Library, Antonio Gutiérrez, 419290

REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH TREATMENT-NAÏVE AND RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES

EHA Library, Jennifer Lue, 419291

COFORMULATED VIBOSTOLIMAB/PEMBROLIZUMAB IN RELAPSED/REFRACTORY NHL AND MM: AN ANALYSIS OF COHORTS C TO F OF THE PHASE 2 KEYVIBE-004 STUDY

EHA Library, Sylvain Choquet, 419292

INITIAL RESULTS FROM THE PRIZM+ PHASE II PLATFORM STUDY FOR RELAPSED AND REFRACTORY PRIMARY CNS LYMPHOMA:  COHORT 1 ZANUBRUTINIB MONOTHERAPY

EHA Library, Christopher Fox, 419293

ANALYSIS OF LARGE B-CELL LYMPHOMA PATIENTS FAILED AFTER CAR T-CELL THERAPY: SEVERAL FACTORS PREDICTING OUTCOME OF RELAPSED/PROGRESSED PATIENTS ARE ALREADY PRESENT BEFORE CELL INFUSION

EHA Library, Robert Pytlík, 419294

CLINICAL CHARACTERISTICS, TREATMENT OPTIONS AND OUTCOME OF REFRACTORY AND EARLY RELAPSE LARGE B CELL LYMPHOMA (LBCL) PATIENTS INCLUDED IN THE REALYSA COHORT BEFORE CAR T CELLS ERA.

EHA Library, Stephanie Guidez, 419295

SINTILIMAB PLUS GEMOX IS AN EFFECTIVE SALVAGE THERAPY IN PATIENTS WITH REFRACTORY⁄RELAPSING NODAL PERIPHERAL T CELL LYMPHOMAS

EHA Library, Xibin Xiao, 419296

PATIENT CHARACTERISTICS, BURDEN OF DISEASE AND HEALTHCARE UTILIZATION IN DIFFUSE LARGE B-CELL LYMPHOMA – AN ANALYSIS OF GERMAN CLAIMS DATA

EHA Library, Moritz Lehne, 419297

DIAGNOSTIC AND PROGNOSTIC IMPACTS OF RHOA G17V MUTATION IN CELL-FREE DNA ASSESSED BY DROPLET DIGITAL POLYMERASE CHAIN REACTION IN PATIENTS WITH ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

EHA Library, Yi Miao, 419298

WAVELINE-004: UPDATED RESULTS FROM THE PHASE 2 STUDY OF ZILOVERTAMAB VEDOTIN (ZV) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Muhit Ozcan, 419299

ENHANCED EFFICACY AND SAFETY FROM PHASE 2 STUDY OF IMC-001, ANTI-PD-L1 ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA (R/R ENKTL), NASAL TYPE: DISTINKT STUDY

EHA Library, Won Seog Kim, 419300

EARLYMIND, A RETROSPECTIVE MULTICENTER STUDY IN REAL-WORLD SETTINGS TO CHARACTERIZE TAFASITAMAB-LENALIDOMIDE EFFICACY IN TRANSPLANT-INELIGIBLE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Charles Herbaux, 419301

PROGNOSTICATION IN SECONDARY CNS LYMPHOMA PATIENTS TREATED WITH MATRIX OR AN ALTERNATIVE (KORFEL ET AL. NCT01148173) INDUCTION REGIMEN AND AUTOLOGOUS STEM CELL TRANSPLANTATION CONSOLIDATION

EHA Library, Fleur de Groot, 419302

OUTCOMES OF ANTHRACYCLINE-BASED CHEMOIMMUNOTHERAPY IN DE NOVO AND TRANSFORMED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Maximilian Seib, 419303

COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY IN PATIENTS WITH LARGE B-CELL LYMPHOMA IN SINGAPORE

EHA Library, Francesca Lim, 419304

THE PHASE II STUDY OF ZANUBRUTINIB COMBINED WITH R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS WITH SPECIFIC GENE-EXPRESSION

EHA Library, Qunling Zhang, 419305

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE AFTER 5797 SOLID-ORGAN TRANSPLANTS OVER A 30-YEAR PERIOD IN A SINGLE HOSPITAL.

EHA Library, Ana Jiménez Ubieto, 419306

INTELLIGENT INTEGRATION: DEEP LEARNING ENSEMBLE CLASSIFIER FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, GLIOMA, AND BRAIN METASTASIS - A RETROSPECTIVE STUDY

EHA Library, Bihui Pan, 419307

MONOMORPHIC LYMPHOPROLIFERATIVE DISORDERS FOLLOWING HEART TRANSPLANTATION: A SINGLE CENTER EXPERIENCE ON 1055 TRANSPLANTS.

EHA Library, Anna Maria Barbui, 419308

A MULTI-CENTER, OPEN-LABEL, PHASE 1/2 STUDY OF ONCT-808, A ROR1-TARGETING CAR-T CELL THERAPY, IN ADULTS WITH RELAPSED/REFRACTORY (R/R) AGGRESSIVE B CELL LYMPHOMAS (BCL)

EHA Library, Michael Wang, 419309

POLATUZUMAB VEDOTIN-INDUCED INNATE IMMUNE CELL INFILTRATION CONTRIBUTES TO ITS ANTITUMOR EFFECT IN A HUMAN DLBCL XENOGRAFT MODEL

EHA Library, Mayu Tomita, 419310

IMPACT OF BCR-IGH DIVERSITY ON PROGNOSIS IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Takahiro Haeno, 419311

MUTANT STAT5B TRIGGERS NK-CELL NEOPLASMS

EHA Library, Dagmar GOTTHARDT, 419312

CD58 GENETIC ALTERATIONS GOVERN ANTITUMOR IMMUNE RESPONSES BY REGULATING PD-L1 AND IDO VIA THE LYN/CD22/SHP1 AXIS IN DLBCL

EHA Library, Xiyue Xu, 419313

INTEGRATION OF [18F]FDG-PET RADIOMICS WITH LIQUID BIOPSY IMPROVES OUTCOME PREDICTION IN NEWLY DIAGNOSED DLBCL PATIENTS

EHA Library, Riccardo Dondolin, 419314

SPECIFIC IMMUNE-MOLECULAR PROFILES DISTINGUISH TESTICULAR DIFFUSE LARGE B-CELL LYMPHOMA FROM NODAL-DLBCL-ABC

EHA Library, Ruben de Groen, 419315

PD-1 AND TIGIT IMMUNE-CHECKPOINT BLOCKADE IN NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA

EHA Library, Maher Gandhi, 419316

CIRCULATING TUMOR DNA ANALYSIS ASSOCIATES WITH PFS WITH ODRONEXTAMAB MONOTHERAPY IN R/R FL AND DLBCL: IDENTIFICATION OF MRD STATUS AND HIGH-RISK SUBGROUPS FROM THE PHASE 2 ELM-2 STUDY

EHA Library, David Tucker, 419317

UNRAVELING THE MECHANISMS OF BCL7A-MEDIATED TUMOR SUPPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA: A MULTI-OMIC APPROACH

EHA Library, Fernando Montenegro Elvira, 419318

ALK INHIBITORS ENHANCE PHAGOCYTOSIS INDUCED BY CD47 BLOCKADE IN SENSITIVE AND RESISTANT ALK+ ALCL

EHA Library, Federica Malighetti, 419319

MICRORNA-1181, UPREGULATED IN BONE MARROW-DERIVED EXTRACELLULAR VESICLES, PROMOTES REDUCED PROLIFERATION CAPACITY AND INCREASED APOPTOSIS OF DLBCL CELLS

EHA Library, Inna Tzoran, 419320

CD19 EXPRESSION PERSISTS IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENT BIOPSIES AFTER TREATMENT WITH TAFASITAMAB

EHA Library, Diana Alvarez Arias, 419321

APAF-1 DOWNREGULATION PROMOTES ANGIOIMMUNOBLASTIC T CELL LYMPHOMA.

EHA Library, Barbara Chalhoub, 419322

UNCOVERING A UNIQUE LEUKEMIC CLONE OF KLRG1-CD8+ EFFECTOR T CELLS IN T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA SENSITIVE TO PI3K INHIBITOR: A PILOT TRIAL

EHA Library, Ruonan Li, 419323

GENE EXPRESSION PROFILING OF RELAPSED AND REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA REVEALS ENRICHMENT OF IMMUNE SIGNALING PATHWAYS

EHA Library, Ya Hwee Tan, 419324

THE MUTATIONAL LANDSCAPE AND ITS PROGNOSTIC IMPACT IN CHINESE PEDIATRIC PATIENTS WITH T-CELL LYMPHOBLASTIC LYMPHOMA

EHA Library, Yonghong Zhang, 419325

RESPONSE IN MOLECULAR SUBGROUPS AND CIRCULATING TUMOR (CT)DNA KINETICS IN PATIENTS WITH RELAPSED AND/OR REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL) TREATED WITH GLOFITAMAB MONOTHERAPY

EHA Library, Carmelo Carlo-Stella, 419326

HYPERSPECTRAL IMAGING FOR NON-INVASIVE DIAGNOSIS OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A PILOT STUDY

EHA Library, Ji Ma, 419327

3D IN-VITRO RECREATED TUMOR MICROENVIRONMENT AFFECTS DLBCL DRUGS SENSITIVITY AND ALTERS THE CYTOKINE MILIEU

EHA Library, Jessica Ceccato, 419328

CDK1 INHIBITOR RO-3306 ENHANCES BTKI POTENCY IN DIFFUSE LARGE B-CELL LYMPHOMA BY SUPPRESSING JAK2/STAT3 SIGNALING

EHA Library, Liang Yu, 419329

THE BLOOD PROTEOME PREDICTS HIGH RISK OF RELAPSE IN MANTLE CELL LYMPHOMA PATIENTS

EHA Library, Patrick Nylund, 419330

IMMUNE CORRELATES OF RESPONSE TO EPCORITAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: DOSE EXPANSION IN A PHASE 1/2 TRIAL

EHA Library, Jimin Zhang, 419331

ROLE OF INFLAMMATION IN WALDENSTROM MACROGLOBULINEMIA: INSIGHTS FROM A MULTICENTER STUDY

EHA Library, Pierre-Edouard Debureaux, 419332

CD20 EXPRESSION AND RESPONSE TO ODRONEXTAMAB: BIOMARKER ANALYSIS IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R B-NHL) FROM THE ELM-2 STUDY

EHA Library, Stefano Luminari, 419333

MYELOID CLONAL HEMATOPOIESIS AFFECTS OUTCOME IN YOUNGER MANTLE CELL LYMPHOMA PATIENTS: UPDATED RESULTS FROM THE FONDAZIONE ITALIANA LINFOMI MCL0208 CLINICAL TRIAL

EHA Library, Simone Ragaini, 419334

GUT MICROBIAL SHORT-CHAIN FATTY ACIDS AS POTENTIAL CHEMICAL MODIFIER OF CAR-T CELLS FOR NON-HODGKIN LYMPHOMA

EHA Library, Roberto Garcia-Vicente, 419335

POPULATION MODELING OF AXICABTAGENE CILOLEUCEL PHARMACOKINETICS IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Sylvain Lamure, 419336

AMINO ACID INFLUX VIA LAT1 REGULATES IRON DEPENDENCY OF AGGRESSIVE NATURAL KILLER CELL LEUKEMIA

EHA Library, Ryo Yanagiya, 419337

PRECLINICAL ASSESSMENT OF IPH6501, A FIRST-IN-CLASS IL2V-ARMED TETRASPECIFIC NK CELL ENGAGER DIRECTED AGAINST CD20 FOR R/R B-NHL, IN COMPARISON WITH A CD20-TARGETING T CELL ENGAGER

EHA Library, Eric Vivier, 419338

LMP1 ENHANCED AEROBIC GLYCOLYSIS VIA COMPETITIVE BINDING WITH TRAF3 TO ACTIVE NF-ΚB PATHWAY IN NATURAL KILLER/T CELL LYMPHOMA

EHA Library, Wenting Song, 419339

ELUCIDATING THE MECHANISM OF HMGB2 IN AUGMENTING THE WARBURG EFFECT AND FACILITATING THE ONSET OF HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMA THROUGH THE REGULATION OF U2AF2 STABILITY

EHA Library, Jun Li, 419340

PLEIOTROPIC RISK LOCI IN LYMPHOID NEOPLASMS: PHENOCLUSTERING REVEALS NOVEL INSIGHTS

EHA Library, Murat Güler, 419342

ORAL ARV-393 IS A BCL6 DEGRADING PROTAC EFFICACIOUS AS MONOTHERAPY IN B-CELL LYMPHOMA PRECLINICAL CDX AND PDX MODELS

EHA Library, Sheryl Gough, 419343

ANTIBIOTIC-ASSOCIATED DYSBIOSIS IMPACTS ON THE PROGRESSION OF NON-HODGKIN LYMPHOMA THROUGH T CELL DYSFUNCTION

EHA Library, María Hernández-Sánchez, 419344